FDA approves the first injection drug -- Apretude (cabotegravir) to prevent HIV infection in late Dec 2021. At roughly the same time, NIH decided to discontinue funding for the Microbicides Trials Network, which had partially supported the development of the dapivirine vaginal ring.

https://www.poz.com/article/hiv-prevention-ring-withdrawn-fda-consideration